Leading probiotic supplement manufacturer, Symprove, is being prepared for a potential sale that could bring in at least £250m. It has been reported that British-based private equity firm, bd-capital, has enlisted the help of investment bankers at Jefferies to facilitate an auction for the company. The process is expected to result in a transaction taking place no earlier than 2025.
